Distomatosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1685B66.0B66.1B66.2
Who is this for?
Show terms as
44Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distomatosis, also known as trematode infection or fluke infection, is a group of parasitic diseases caused by trematode flatworms (flukes) that infect various organ systems in the human body. This condition encompasses several distinct infections depending on the causative organism and the organ affected, including opisthorchiasis (liver flukes such as Opisthorchis felineus and Opisthorchis viverrini), clonorchiasis (Clonorchis sinensis), dicrocoeliasis (Dicrocoelium dendriticum), fascioliasis (Fasciola hepatica and Fasciola gigantica), fasciolopsiasis (Fasciolopsis buski), and other fluke infections. Humans typically acquire these infections through consumption of raw or undercooked freshwater fish, aquatic plants, or contaminated water containing encysted larvae (metacercariae). The body systems most commonly affected include the hepatobiliary system (liver and bile ducts), the intestinal tract, and in some species the lungs or blood vessels. Hepatic flukes cause inflammation of the bile ducts (cholangitis), hepatomegaly, biliary obstruction, and in chronic cases may lead to cholangiocarcinoma (bile duct cancer), particularly with Opisthorchis viverrini and Clonorchis sinensis infections. Intestinal flukes such as Fasciolopsis buski cause abdominal pain, diarrhea, malabsorption, and intestinal obstruction. Key symptoms across the group include fever, abdominal pain, hepatomegaly, eosinophilia, jaundice, fatigue, and gastrointestinal disturbances. During the acute migratory phase of fascioliasis, patients may experience high fever, urticaria, and marked eosinophilia. Treatment is available and generally effective. The antiparasitic drug praziquantel is the mainstay of therapy for most fluke infections, including opisthorchiasis, clonorchiasis, and intestinal fluke infections. Triclabendazole is the drug of choice for fascioliasis, as Fasciola species do not respond well to praziquantel. Supportive care may be needed for complications such as biliary obstruction or secondary bacterial cholangitis. Prevention strategies focus on food safety measures, including thorough cooking of freshwater fish and aquatic vegetables, and public health interventions in endemic regions, particularly in Southeast Asia, East Asia, and parts of South America and Africa.

Also known as:

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

6 events
Mar 2026Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension

Caio Júlio César dos Santos Fernandes

TrialNOT YET RECRUITING
Aug 2025One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis

Universidad Peruana Cayetano Heredia — PHASE2

TrialNOT YET RECRUITING
Feb 2025MATCHING - feMAle geniTal sCHistosomiasis IN miGrants Female Genital Schistosomiasis in Migrants Presenting to an Outpatient Clinic in Italy: Prevalence and Clinical Impact

IRCCS Sacro Cuore Don Calabria di Negrar — NA

TrialRECRUITING
Oct 2023Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.

Assiut University

TrialNOT YET RECRUITING
Feb 2022Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Novartis Pharmaceuticals — PHASE4

TrialACTIVE NOT RECRUITING
Aug 2000Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

National Institute of Allergy and Infectious Diseases (NIAID) — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Distomatosis.

View clinical trials →

No actively recruiting trials found for Distomatosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distomatosis community →

Specialists

Showing 25 of 44View all specialists →
HZ
Hongliang Zhang
Specialist
PI on 1 active trial1094 Distomatosis publications
BP
Bruno Levecke, PhD
Specialist
PI on 3 active trials
RD
Rita Wegmüller, Dr.
Specialist
PI on 1 active trial
HM
Helen McShane
Specialist
PI on 13 active trials2 Distomatosis publications
PM
Pranay Sinha, MD
BOSTON, MA
Specialist
PI on 3 active trials
TM
Thomas B Nutman, M.D.
BETHESDA, MD
Specialist
PI on 7 active trials
AM
Amy D Klion, M.D.
BETHESDA, MD
Specialist
PI on 8 active trials
AM
Alexandra F Freeman, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 2 active trials
MM
Michael Mayr, MD
Bagamoyo, Coast Region
Specialist

Rare Disease Specialist

PI on 2 active trials
WP
Wendy O'Meara, PhD
Specialist
PI on 3 active trials
KP
Katja Polman, PhD
Specialist
PI on 1 active trial
MP
Marleen Boelaert, PhD
Specialist
PI on 1 active trial
JP
Jürg Utzinger, PhD
Specialist
PI on 1 active trial
SM
Steven J Reynolds, M.D.
Specialist
PI on 3 active trials
JC
Jean Coulibaly
Specialist
PI on 1 active trial
SD
Shally Awasthi, MD, DNB
Specialist
PI on 1 active trial
AP
Annette Olsen, PhD
NASHVILLE, TN
Specialist
PI on 1 active trial
AP
Allen Nalugwa, PhD
Specialist
PI on 1 active trial
GP
Gilles RIVEAU, PharmD, PhD
Specialist
PI on 1 active trial
FP
Fred Nuwaha, PhD
Specialist
PI on 1 active trial
EP
Edridah Muheki, PhD
Specialist
PI on 1 active trial
AC
Anne-Marie SCHACHT, CRA
Specialist
PI on 1 active trial
EP
Elijah M Songok, PhD
Specialist
PI on 1 active trial
MM
Modou DIOP, MD
Specialist
PI on 1 active trial
PP
Peter Steinmann, PhD PD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
⚗️ Trial Site

National Institutes of Health Clinical Center

📍 Bethesda, Maryland

👤 Payal P Khincha, M.D.

👤 Christopher Grunseich, M.D.

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

Financial Resources

1 resources

NOXAFIL

Merck

Fungal infection

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications

Travel Grants

No travel grants are currently matched to Distomatosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open DistomatosisForum →

No community posts yet. Be the first to share your experience with Distomatosis.

Start the conversation →

Latest news about Distomatosis

Disease timeline:

New recruiting trial: Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

A new clinical trial is recruiting patients for Distomatosis

New recruiting trial: MATCHING - feMAle geniTal sCHistosomiasis IN miGrants Female Genital Schistosomiasis in Migrants Presenting to an Outpatient Clinic in Italy: Prevalence and Clinical Impact

A new clinical trial is recruiting patients for Distomatosis

New recruiting trial: Comorbidities and Coinfections in Latent TB

A new clinical trial is recruiting patients for Distomatosis

New recruiting trial: Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study

A new clinical trial is recruiting patients for Distomatosis

New trial: Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome

Phase NA trial recruiting.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distomatosis

What is Distomatosis?

Distomatosis, also known as trematode infection or fluke infection, is a group of parasitic diseases caused by trematode flatworms (flukes) that infect various organ systems in the human body. This condition encompasses several distinct infections depending on the causative organism and the organ affected, including opisthorchiasis (liver flukes such as Opisthorchis felineus and Opisthorchis viverrini), clonorchiasis (Clonorchis sinensis), dicrocoeliasis (Dicrocoelium dendriticum), fascioliasis (Fasciola hepatica and Fasciola gigantica), fasciolopsiasis (Fasciolopsis buski), and other fluke in

Which specialists treat Distomatosis?

25 specialists and care centers treating Distomatosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Distomatosis?

1 patient support program are currently tracked on UniteRare for Distomatosis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.